Specialized Peripheral Nerve Stimulation Systems for Inflammatory Bowel Disease Treatment in Extreme Environments

Publication ID: 24-11857778_0004_PTD
Published: October 28, 2025
Category:Specialized Variations & Niche Solutions

Legal Citation

pr1or.art Inc., “Specialized Peripheral Nerve Stimulation Systems for Inflammatory Bowel Disease Treatment in Extreme Environments,” Published Technical Disclosure No. 24-11857778_0004_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857778_0004_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,778.

Summary of the Inventive Concept

This inventive concept adapts peripheral nerve stimulation technology for treating inflammatory bowel disease to specific, challenging operational environments, such as high-altitude, disaster relief, high-security, extreme weather, and remote or rural areas.

Background and Problem Solved

The original patent for peripheral nerve stimulation systems for treating inflammatory bowel disease has limitations when applied to specific, niche environments. For instance, traditional systems may not be optimized for low-oxygen conditions, high-security settings, or remote areas with limited connectivity. This inventive concept addresses these limitations by developing specialized systems and methods tailored to these unique environments.

Detailed Description of the Inventive Concept

The new claims describe systems and methods for treating inflammatory bowel disease in various extreme environments. For example, Claim 1 describes a portable peripheral nerve stimulator adapted for use in low-oxygen conditions, with a power source optimized for extended battery life. Claim 2 details a method for treating symptoms of Crohn's disease in a disaster relief setting, utilizing real-time feedback from a vital signs monitor to adjust the electrical nerve stimulation signal. Similarly, Claim 3 describes a secure peripheral nerve stimulator with biometric authentication for high-security environments, while Claim 4 outlines a method for treating irritable bowel syndrome in extreme weather conditions, using real-time feedback from a weather monitoring system. Finally, Claim 5 presents a system for treating microscopic colitis in remote or rural areas, featuring a portable peripheral nerve stimulator with satellite connectivity and a telemedicine platform for remote consultation and treatment monitoring.

Novelty and Inventive Step

The new claims introduce novel and non-obvious adaptations of peripheral nerve stimulation technology for treating inflammatory bowel disease in extreme environments. These adaptations include the development of portable, low-oxygen optimized stimulators, secure stimulators with biometric authentication, and systems with real-time feedback from vital signs or weather monitoring systems. These innovations provide a significant improvement over traditional systems and enable effective treatment in challenging operational environments.

Alternative Embodiments and Variations

Alternative embodiments of this inventive concept could include specialized systems for treating other inflammatory diseases in extreme environments, such as rheumatoid arthritis in high-altitude settings or autoimmune hepatitis in disaster relief scenarios. Variations may also involve different types of sensors or monitoring systems, such as wearable devices or mobile applications, to provide real-time feedback and adjust the electrical nerve stimulation signal.

Potential Commercial Applications and Market

This inventive concept has significant commercial potential in various industries, including healthcare, disaster relief, and national security. The market for specialized peripheral nerve stimulation systems for treating inflammatory bowel disease in extreme environments is substantial, with potential customers including government agencies, non-profit organizations, and private companies operating in these environments.

Original Patent Information

Patent NumberUS 11,857,778
TitleSystems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
Assignee(s)Cala Health, Inc.